Lidocaine Kade (Lidocaine)

Lidocaine works by reversibly blocking voltage‑gated sodium channels on nerve fibers. This inhibition stops the influx of sodium ions needed for the generation and propagation of nerve impulses, resulting in a rapid loss of sensation in the area where the drug is applied.

The appropriate dose of Lidocaine Kade is determined by the prescribing healthcare professional based on the specific procedure, patient age, weight, and clinical condition. Only a qualified prescriber should set the dosage and administration schedule.

Safety data for Lidocaine Kade in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for short‑term rectal procedures. Compared with agents like bupivacaine, lidocaine has a shorter half‑life and lower risk of prolonged motor block, but may require repeat dosing for longer procedures.

Lidocaine Kade should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain its stability and potency.

Lidocaine Kade is administered rectally, typically as a topical gel, ointment, or suppository applied directly to the mucosal surface of the rectum. The exact form and method are defined by the prescriber and the product’s labeling.

Serious risks include systemic toxicity leading to seizures, cardiac arrhythmias, severe allergic reactions (anaphylaxis), and methemoglobinemia. Prompt recognition of symptoms such as dizziness, tinnitus, metallic taste, or cardiovascular changes is essential, and medical attention should be sought immediately.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe liver disease, or individuals taking medications that significantly raise lidocaine plasma levels (e.g., certain antiarrhythmics) should avoid using this product unless specifically directed by a healthcare professional.